Skip to main content

Advertisement

SpringerLink
Log in

Clinical Manifestations, Diagnosis, and Treatment of Neurocysticercosis

  • Infection (Burk Jubelt, Section Editor)
  • Published:
Current Neurology and Neuroscience Reports Aims and scope Submit manuscript

Abstract

Neurocysticercosis (NCC) is the most frequent parasitic disease of the human brain. Modern imaging studies, CT and MRI, have defined the diagnosis and characterization of the disease. Through these studies the therapeutic approach for each case may be individualized with the aid of antihelmintics, steroids, symptomatic medicines, or surgery. The use of one or various therapeutic measures largely depends on the peculiar combination of number, location, and biological stage of lesions as well as the degree of inflammatory response to the parasites. Although there is not a typical clinical picture of NCC, epilepsy is the most frequent manifestation of parenchymal NCC, whereas hydrocephalus is the most frequent manifestation of meningeal NCC. Eradication of cysticercosis is an attainable goal by public education and sanitary improvement in endemic areas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Garcia H, Del Bruto OH. Neurocysticercosis: updated concepts about an old disease. Lancet Neurol. 2005;4:653–61.

    Article  PubMed  Google Scholar 

  2. Quet F, Guerchet M, Pion SD, et al. Meta-analysis of the association between cysticercosis and epilepsy in Africa. Epilepsia. 2010;51:830–7.

    PubMed  Google Scholar 

  3. •• Sinha S, Sharma BS. Neurocysticercosis: a review of current status and management. J ClinNeurosci. 2009;16:867–76. This review is practical and comprehensive with figures and photographs that clearly exemplify the complex pathophysiology of NCC and it includes a good selection of relevant references too.

    Article  Google Scholar 

  4. Sorvillo FJ, DeGiorgio C, Waterman SH. Deaths from Cysticercosis, United States. Emerg Infect Dis. 2007;13:230–5.

    Article  PubMed  Google Scholar 

  5. Sorvillo F, Wilkins P, Shafir S, et al. Public health implications of cysticercosis acquired in the United States. Emerg Infect Dis. 2011;17:1–6.

    Article  PubMed  Google Scholar 

  6. •• Coyle CM, Tanowitz HB. Diagnosis and Treatment of Neurocysticercosis. Interdiscip Perspect Infect Dis 2009, 2009: doi:10.1155/2009/180742. This is a thoroughly comprehensive and updated review that joins classical and modern concepts on the evolving field of NCC, particularly in regard to therapeutics.

  7. Croker C, Reporter R, Mascola L. Use of Statewide hospital discharge data to evaluate the economic burden of neurocysticercosis in Los Angeles County (1991–2008). Am J Trop Med Hyg. 2010;83:106–10.

    Article  PubMed  Google Scholar 

  8. Holmes NE, Iles LE, Danks RA, et al. Neurocysticercosis causing sudden death. Am J Forensic Med Pathol. 2010;31:117–9.

    Article  PubMed  Google Scholar 

  9. Salgado P, Rojas R, Sotelo J. Clinical classification based on imaging studies. Arch Intern Med. 1997;157:1991–7.

    Article  PubMed  CAS  Google Scholar 

  10. Sotelo J, Escobedo F, Rodríguez J, et al. Therapy of parenchymal brain cysticercosis with praziquantel. N Engl J Med. 1984;310:1001–7.

    Article  PubMed  CAS  Google Scholar 

  11. Escobedo F, Penagos P, Rodríguez J, et al. Albendazole therapy for neurocysticercosis. Arch Intern Med. 1987;147:738–41.

    Article  PubMed  CAS  Google Scholar 

  12. Sotelo J, Diaz-Olavarrieta C. Neurocysticercosis: changes after 25 years of medical therapy. Arch Med Res. 2010;41:62–3.

    Article  PubMed  Google Scholar 

  13. Sotelo J. Neurocysticercosis. Eradication of cysticercosis is an attainable goal. BMJ. 2003;326:511–2.

    Article  PubMed  Google Scholar 

  14. Sotelo J, Guerrero V, Rubio F. Neurocysticercosis: a new classification based on active and inactive forms. A study of 753 cases. Arch Intern Med. 1985;145:442–5.

    Article  PubMed  CAS  Google Scholar 

  15. Ciampi de Andrade D, Rodrigues CL, Abraham R, et al. Cognitive impairment and dementia in neurocysticercosis. Neurology. 2010;74:1288–95.

    Article  PubMed  CAS  Google Scholar 

  16. Kelesidis T, Tsiodras S. Hypopituitarism caused by Neurocysticercosis. Am J Med Sci. 2011;341:414–6.

    Article  PubMed  Google Scholar 

  17. Jayaraman T, Prabhakaran V, Babu P, et al. Relative seroprevalence of cysticercus antigens and antibodies and antibodies to Taenia ova in a population sample in south India suggest immunity against neurocysticercosis. Trans R Soc Trop Med Hyg. 2011;105:153–9.

    Article  PubMed  CAS  Google Scholar 

  18. Praet N, Speybroeck N, Rodriguez-Hidalgo R, et al. Age-related infection and transmission patterns of human cysticercosis. Int J Parasitol. 2010;40:85–90.

    Article  PubMed  CAS  Google Scholar 

  19. García HH, Gonzalez AE, Rodriguez S, et al. Neurocysticercosis: unraveling the nature of the single cysticercal granuloma. Neurology. 2010;75:654–8.

    Article  PubMed  Google Scholar 

  20. •• Rajshekar V. Surgical management of neurocysticercosis. Int J Surg. 2010;8:100–4. This review represents a well-documented status on the surgical aspects of NCC, and it offers an equilibrated view of surgical options in addition to drug therapy.

    Article  Google Scholar 

  21. Fleury A, Carrillo-Mezo R, Flisser A, et al. Subarachnoid basal neurocysticercosis: a focus on the most severe form of the disease. Expert Rev Anti Infect Ther. 2011;9:123–33.

    Article  PubMed  Google Scholar 

  22. • Moskowitz J, Mendelsohn G. Neurocysticercosis. Arch Pathol Lab Med. 2010;134:1560–3. This is a brief summary of important facts about NCC.

    PubMed  Google Scholar 

  23. Ndimubanzi PC, Carabin H, Budke CM, et al. A systemic review of the frequency of neurocysticercosis with a focus on people with epilepsy. PLos Negl Trop Dis. 2010;4:e870. doi:10:1371/journal.pntd.0000870.

    Article  PubMed  Google Scholar 

  24. Winkler AS, Willingham 3rd AL, Sikasunge CS, et al. Epilepsy and neurocysticercosis in sub-Saharan Africa. Wien Klin Wochenschr. 2009;3:3–12.

    Article  Google Scholar 

  25. Raghava MV, Prabhakaran V, Jayaraman T, et al. Detecting spatial clusters of Taenia solium infections in a rural block in South India. Trans R Soc Trop Med Hyg. 2010;104:601–12.

    Article  PubMed  Google Scholar 

  26. Alexander AM, Prabhakaran V, Rajshekhar V, et al. Long-term clinical evaluation of asymptomatic subjects positive for circulating Taenia solium antigens. Trans R Soc Trop Med Hyg. 2010;104:809–10.

    Article  PubMed  CAS  Google Scholar 

  27. Lundström J, Salazar-Anton F, Sherwood E, et al. Analyses of an expressed sequence tag library from Taeniasolium, Cysticerca. PLoS Negl Trop Dis. 2010;4:e919. doi:10.1371/journal.pntd.0000919.

    Article  PubMed  Google Scholar 

  28. Kaur P, Dhiman P, Dhawan N, et al. Comparison of 1 week versus 4 weeks of albendazole therapy in single small enhancing computed tomography lesion. Neurol India. 2010;58:560–4.

    Article  PubMed  Google Scholar 

  29. Abba K, Ramaratnam S, Ranganathan LN. Anthelmintics for people with neurocysticercosis. Cochrane Database Syst Rev 2010, doi:10.1002/14651858.CD000215.pub4.

  30. Sotelo J. Neurocysticercosis: is the elimination of parasites beneficial? N Engl J Med. 2004;350:280–2.

    Article  PubMed  CAS  Google Scholar 

  31. Uddin J, Gonzalez AE, Gilman RH, et al. Mechanisms regulating monocyte CXCL8 secretion in neurocysticercosis and the effect of antiparasitic therapy. J Immunol. 2010;185:4478–84.

    Article  PubMed  CAS  Google Scholar 

  32. Goel D, Mittal M, Bansal KK, et al. Natural history of solitary cerebral cysticercosis cases after albendazole therapy: a longitudinal follow-up study from India. Acta Neurol Scand. 2010;121:204–8.

    Article  PubMed  CAS  Google Scholar 

  33. Ramírez-Zamora A, Alarcón T. Management of neurocysticercosis. Neurol Res. 2010;32:229–37.

    Article  PubMed  Google Scholar 

  34. Chaurasia RN, Garg RK, Agarwall A, et al. Three day albendazole therapy in patients with a solitary cysticercus granuloma: a randomized double blind placebo controlled study. Southeast Asian J Trop Med Public Health. 2010;41:517–25.

    PubMed  Google Scholar 

  35. Sotelo J, Jung H. Pharmacokinetic optimisation of the treatment of neurocysticercosis. Clin Pharmacokinet. 1998;34:503–15.

    Article  PubMed  CAS  Google Scholar 

  36. Mahanty S, Paredes A, Marzal M, et al. A sensitive in vitro system to assess morphological and biochemical effects of praziquantel and albendazole on Taenia solium cysts. Antimicrob Agents Chemother. 2011;55:211–7.

    Article  PubMed  CAS  Google Scholar 

  37. Mishra BB, Gundra UM, Teale JM. Toll-like receptors in CNS parasitic infections. Curr Top Microbiol Immunol. 2009;336:83–104.

    Article  PubMed  CAS  Google Scholar 

  38. Sotelo J, Arriada N, Lopez MA. Ventriculoperitoneal shunt of continuous flow vs valvular shunt for treatment of hydrocephalus in adults. Surg Neurol. 2005;63:197–203.

    Article  PubMed  Google Scholar 

  39. De Souza A, Thennarasu K, Yeshraj G, et al. Randomized controlled trial of albendazole in new onset epilepsy and MRI confirmed solitary cerebral cysticercal lesion: effect on long-term seizure outcome. J Neurol Sci. 2009;276:108–14.

    Article  PubMed  Google Scholar 

  40. Proaño JV, Torres-Corzo J, Rodríguez-Della Vecchia R, et al. Intraventricular and subarachnoid basal cisterns neurocysticercosis: a comparative study between traditional treatment versus neuroendoscopic surgery. Childs Nerv Syst. 2009;25:1467–75.

    Article  PubMed  Google Scholar 

  41. Torres-Corzo JG, Tapia-Pérez JH, Vechhia RR, et al. Endoscopic management of hydrocephalus due to neurocysticercosis. Clin Neurol Neurosurg. 2010;112:11–6.

    Article  PubMed  Google Scholar 

  42. Flisser A, Correa D. Neurocysticercosis may no longer be a public health problem in Mexico. PLoS Negl Trop Dis. 2010;4:e831. doi:10.1371/journal.pntd.0000831.

    Article  PubMed  Google Scholar 

  43. Fleury A, Moreno Garcia J, Valdez Aguerrebere P, et al. Neurocysticercosis, a persisting health problem in Mexico. PLoS Negl Trop Dis. 2010;4:e805. doi:10.1371/journal.pntd.0000805.

    Article  PubMed  Google Scholar 

  44. Pybus M, Heron P. Neurocysticercosis: An unusual cause of seizure in the New Zealand setting. J Paediatr Child Health 2011, doi:10.1111/j.1440-1754.2010.01971.x

  45. Moroni S, Moscatelli G, Freilij H, et al. Neurocysticercosis: report of an autochthonous case in Buenos Aires city. Arch Argent Pediatr. 2010;108:e143–146.

    PubMed  Google Scholar 

  46. Medina MT, Aguilar-Estrada RL, Alvarez A, et al. Reduction in rate of epilepsy from neurocysticercosis by community interventions: The Salamá, Honduras study. Epilepsia 2011, doi:10.1111/j.1528-1167.2010.02945.x.

  47. Willingham 3rd AL, Wu HW, Conian J, et al. Combating Taenia solium cysticercosis in Southeast Asia an opportunity for improving human health and livestock production. Adv Parasitol. 2010;72:235–66.

    Article  PubMed  Google Scholar 

Download references

Disclosure

No potential conflict of interest relevant to this article was reported.

Author information

Authors and Affiliations

  1. The Neuroimmunology Unit, National Institute of Neurology and Neurosurgery of Mexico, Insurgentes Sur 3877, Mexico City, 14269, Mexico

    Julio Sotelo

Authors
  1. Julio Sotelo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Julio Sotelo.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sotelo, J. Clinical Manifestations, Diagnosis, and Treatment of Neurocysticercosis. Curr Neurol Neurosci Rep 11, 529–535 (2011). https://doi.org/10.1007/s11910-011-0226-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11910-011-0226-7

Keywords

Search

Navigation